Compare LITE & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LITE | BSX |
|---|---|---|
| Founded | 2015 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.1B | 65.8B |
| IPO Year | 2015 | 2010 |
| Metric | LITE | BSX |
|---|---|---|
| Price | $925.60 | $51.72 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 22 |
| Target Price | ★ $645.43 | $93.18 |
| AVG Volume (30 Days) | 4.6M | ★ 18.4M |
| Earning Date | 05-05-2026 | 04-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 104.56 | 55.20 |
| EPS | ★ 2.59 | 1.51 |
| Revenue | $1,247,700,000.00 | ★ $9,076,000,000.00 |
| Revenue This Year | $79.88 | $11.85 |
| Revenue Next Year | $66.61 | $10.16 |
| P/E Ratio | $361.39 | ★ $34.05 |
| Revenue Growth | ★ 24.57 | 12.49 |
| 52 Week Low | $111.20 | $42.20 |
| 52 Week High | $1,085.68 | $109.50 |
| Indicator | LITE | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 60.65 | 71.64 |
| Support Level | $810.55 | $42.32 |
| Resistance Level | $945.25 | $58.35 |
| Average True Range (ATR) | 78.19 | 1.70 |
| MACD | 20.75 | 0.71 |
| Stochastic Oscillator | 91.76 | 99.56 |
Lumentum Holdings Inc is a California-based technology firm. The company provides two types of optical and photonic products: optical components that are used in telecommunications networking equipment, and commercial lasers for manufacturing, inspection, and life-science lab uses. Its segments are Optical Communications and Commercial Lasers. The firm is also expanding into new optical applications, such as 3-D sensing laser diode for consumer electronics. It generates maximum revenue from the OpComms segment. The OpComms segment products include a wide range of components, modules, and subsystems to support customers including carrier networks for access (local), metro (intracity), long-haul, and submarine (undersea) applications.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.